Background: Although the individual and economic disease burden of depression is particularly high for long-term symptoms, little is known of the lifetime course of chronic depression. Most evidence derives from clinical samples, and the diagnostic distinction between persistent depressive disorder (PDD) and non-chronic major depression (NCMDD) is still debated. Thus, we examined characteristics of PDD among clinical vs. non-clinical cases, and the associated disease burden at a population level. Methods: Data were drawn from the mental health module of the German Health Interview and Examination Survey for Adults (DEGS1-MH, 2009-2012, n = 4483) and a clinical sample of PDD inpatients at Charité -Universitätsmedizin Berlin (2018-2019, n = 45). The DSM-5 definition of PDD was operationalized a priori to the study using interview-based DSM-IV diagnoses of dysthymia and major depression lasting at least 2 years in both surveys. Additional depression characteristics (depression onset, self-classified course, suicidality, comorbid mental disorders, treatment history and current depressive symptoms [Patient Health Questionnaire-9]) were assessed. In the DEGS1-MH, health-related quality of life (Short Form Health Survey-36, SF-36), chronic somatic conditions, number of sick days (past 12 months) or days with limitations in normal daily life activities (past 4 weeks), and health service utilization (past 12 months) were compared for PDD vs. NCMDD. Results: PDD cases from the clinical sample had a significantly earlier depression onset, a higher proportion of selfclassification as persistent course, and treatment resistance than PDD and NCMDD cases in DEGS1-MH. At a population level, PDD cases showed worse outcomes compared with NCMDD cases in terms of somatic comorbidity, SF-36 mental component score, and activity limitations owing to mental health problems, as well as a higher risk for outpatient mental health care contact. Conclusions: The distinction between PDD and NCMDD proposed for DSM-5 seems warranted. Early onset depression, selfclassification as persistent depressive course, and treatment resistance are suggested as markers of more severe and chronic depression courses. At a population level, PDD is associated with remarkably higher individual and economic disease burden than NCMDD, highlighting the need to improve medical recognition of chronic courses and establish specific treatment concepts for chronic depression.
The regional inequality of physician and psychotherapist density cannot be explained by regional differences in treatment needs. The results indicate potential improvements in healthcare provision for mental disorders in Germany through the adaptation to actual morbidity rates; however, the definition of treatment needs in mental disorders requires further evaluation.
No abstract
No abstract
Zusammenfassung Hintergrund: Der Zugang zum Versorgungssystem hängt für Menschen mit psychischen Störungen maßgeblich vom Wohnort ab, da die Dichte von Haus- und Fachärzten in Deutschland erheblich variiert. Ob die regionalen Unterschiede in den Angebotsstrukturen entsprechende Unterschiede auf der Nachfrageseite reflektieren, ist bisher nicht eindeutig zu beantworten. Ziel: Im vorliegenden Artikel werden die räumlichen Disparitäten in der ambulanten Arztdichte von Hausärzten, Nervenärzten und Psychotherapeuten in Deutschland dargestellt und hinsichtlich ihrer Bedarfsgerechtigkeit diskutiert. Dazu müssen Versorgungsunterschiede mit dem Krankheitsstatus und der Krankheitslast einer Region in Bezug gesetzt werden. Ergebnis: Die Nutzung von Diagnoseraten aus Routinedaten der gesetzlichen Krankenversicherungen zu diesem Zweck zeigt Zusammenhänge zwischen Angebotsstrukturen und Morbidität, die in ihrer Aussagekraft jedoch limitiert sind. Hier bieten Auswertungen epidemiologischer Studien, die die „wahren“ Prävalenzen von psychischen Störungen untersuchen, einen wesentlichen Beitrag für eine evidenzbasierte Bedarfsplanung.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.